Stock Scorecard
Stock Summary for uniQure N.V. (QURE) - $13.94 as of 6/30/2025 9:28:03 PM EST
Total Score
9 out of 30
Safety Score
33 out of 100
Currently on the following lists
None
Tim's Recommendation
Avoid
Growth List Algorithm Criteria for QURE
Positive Quarterly and Annual earnings growth | |
P/E ratio less than Industry P/E Ratio | |
P/E ratio less than Sector P/E Ratio | |
P/E ratio that is half the Annual earnings growth rate (or less) | |
Positive net cash position the past year and most recent quarter | |
Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
Positive net income past year and 12 trailing months | |
Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for QURE
Revenue growing by at least 20% average per year over the last 5 years | |
Market Capitalization under 2 billion | |
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for QURE
Declared an ex-dividend date | |
Forward annual dividend rate greater than 2 | |
Positive net cash position the past year and most recent quarter | |
Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
Current ratio most recent quarter greater than 2 | |
Cash Flow per Share greater than Trailing Dividend Rate |
Bonus Criteria for QURE
P/E ratio less than five-year Average P/E ratio | |
Last Price to 52 Week Low Ratio Less Than 1 | |
Total Cash Per Share > Last Day Price | |
P/S Ratio < 1 | |
P/B Ratio < 1 |
Safety Rating Criteria for QURE (33 out of 100)
Stock Price Rating (Max of 10) | 5 |
Historical Stock Price Rating (Max of 10) | 7 |
Stock Price Trend (Max of 10) | 2 |
Book Value (Max of 10) | 1 |
Book Value to Price (Max of 10) | 0 |
Analyst Buy Ratings (Max of 5) | 5 |
Analyst Strong Buy Ratings (Max of 5) | 4 |
Dividend Yield Percentage (Max of 10) | 0 |
Operating Margin (Max of 10) | 0 |
Trading Volume (Max of 10) | 9 |
Price to Earnings (Max of 10) | 0 |
Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) | 0 |
Latest News for for QURE
Financial Details for QURE
Company Overview |
|
---|---|
Ticker | QURE |
Company Name | uniQure N.V. |
Country | USA |
Description | uniQure NV, a gene therapy company, is dedicated to developing treatments for patients suffering from genetic and other devastating diseases. The company is headquartered in Amsterdam, the Netherlands. |
Sector Name | LIFE SCIENCES |
Industry Name | PHARMACEUTICAL PREPARATIONS |
Most Recent Quarter | 3/31/2025 |
Next Earnings Date | N/A |
Stock Price History |
|
Last Day Price | 13.94 |
Price 4 Years Ago | 20.74 |
Last Day Price Updated | 6/30/2025 9:28:03 PM EST |
Last Day Volume | 1,185,715 |
Average Daily Volume | 1,305,325 |
52-Week High | 19.18 |
52-Week Low | 3.73 |
Last Price to 52 Week Low | 273.73% |
Valuation Measures |
|
Trailing PE | N/A |
Industry PE | 22.52 |
Sector PE | 40.73 |
5-Year Average PE | -4.94 |
Free Cash Flow Ratio | 3.51 |
Industry Free Cash Flow Ratio | 17.94 |
Sector Free Cash Flow Ratio | 32.54 |
Current Ratio Most Recent Quarter | 11.99 |
Total Cash Per Share | 3.97 |
Book Value Per Share Most Recent Quarter | 0.62 |
Price to Book Ratio | 22.56 |
Industry Price to Book Ratio | 35.01 |
Sector Price to Book Ratio | 30.79 |
Price to Sales Ratio Twelve Trailing Months | 38.51 |
Industry Price to Sales Ratio Twelve Trailing Months | 123.25 |
Sector Price to Sales Ratio Twelve Trailing Months | 35.57 |
Analyst Buy Ratings | 9 |
Analyst Strong Buy Ratings | 2 |
Share Statistics |
|
Total Shares Outstanding | 54,748,000 |
Market Capitalization | 763,187,120 |
Institutional Ownership | N/A |
Dividends |
|
Ex-Dividend Date | N/A |
Previous Dividend Amount | 0.0000 |
Current Dividend Amount | 0.0000 |
Total Years Dividend Increasing | N/A |
Trailing Annual Dividend Rate | 0.00 |
Trailing Annual Dividend Yield | 0.00% |
Forward Annual Dividend Rate | 0.00 |
Forward Annual Dividend Yield | 0.00% |
5-Year Dividend Payments Count | 0 |
3-Year Average Dividend Yield | 0.00% |
5-Year Average Dividend Yield | 0.00% |
1-Year Dividend Growth Rate Percentage | 0.00% |
3-Year Dividend Growth Rate Percentage | 0.00% |
5-Year Dividend Growth Rate Percentage | 0.00% |
All-Time Dividend Growth Rate Percentage | 0.00% |
Dividend Payout Ratio | N/A |
Income Statement |
|
Quarterly Earnings Growth YOY | -18.20% |
Annual Earnings Growth | 22.34% |
Reported EPS 12 Trailing Months | -4.38 |
Reported EPS Past Year | -0.73 |
Reported EPS Prior Year | -4.80 |
Net Income Twelve Trailing Months | -217,575,000 |
Net Income Past Year | -239,556,000 |
Net Income Prior Year | -308,478,000 |
Quarterly Revenue Growth YOY | -81.50% |
5-Year Revenue Growth | 30.08% |
Operating Margin Twelve Trailing Months | -2,815.00% |
Balance Sheet |
|
Total Cash Most Recent Quarter | 217,229,000 |
Total Cash Past Year | 158,930,000 |
Total Cash Prior Year | 241,360,000 |
Net Cash Position Most Recent Quarter | 165,637,000 |
Net Cash Position Past Year | 107,606,000 |
Long Term Debt Past Year | 51,324,000 |
Long Term Debt Prior Year | 101,749,000 |
Total Debt Most Recent Quarter | 51,592,000 |
Equity to Debt Ratio Past Year | -0.15 |
Equity to Debt Ratio Most Recent Quarter | 0.40 |
Total Stockholder Equity Past Year | -6,752,000 |
Total Stockholder Equity Prior Year | 207,670,000 |
Total Stockholder Equity Most Recent Quarter | 33,686,000 |
Free Cash Flow |
|
Free Cash Flow Twelve Trailing Months | -167,085,913 |
Free Cash Flow Per Share Twelve Trailing Months | -3.05 |
Free Cash Flow Past Year | -186,096,000 |
Free Cash Flow Prior Year | -153,083,000 |
Options |
|
Put/Call Ratio | 0.09 |
Has Options | Options Chain |
Liquidity Rating | |
Technical Analysis |
|
Yahoo Finance Chart | Yahoo Finance Chart |
MACD | 0.02 |
MACD Signal | 0.30 |
20-Day Bollinger Lower Band | 9.72 |
20-Day Bollinger Middle Band | 13.49 |
20-Day Bollinger Upper Band | 17.26 |
Beta | 0.09 |
RSI | 45.84 |
50-Day SMA | 10.80 |
150-Day SMA | 12.27 |
200-Day SMA | 14.78 |
System |
|
Modified | 6/28/2025 8:51:53 AM EST |